Dr Douglas Mann Discusses Novel CRISPR/Cas9 Findings in ATTR Amyloid Cardiomyopathy

[ad_1] Douglas L. Mann, MD, professor of medicine at Washington University School of Medicine in St. Louis. Louis and editor-in-chief of JACC: Foundation for Translational Science discussed the first set of data reported in NTLA-2001, a new investigational intravenous agent targeting TTR levels of TTR genes and proteins, which have been shown to play a… Continue reading Dr Douglas Mann Discusses Novel CRISPR/Cas9 Findings in ATTR Amyloid Cardiomyopathy